{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T03:44:01Z","timestamp":1776915841581,"version":"3.51.2"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21lk0201701"],"award-info":[{"award-number":["JP21lk0201701"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["23mk0101234h0002"],"award-info":[{"award-number":["23mk0101234h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21lk0201701"],"award-info":[{"award-number":["JP21lk0201701"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Syst"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Signal detection is essential for identifying potential safety issues with drugs and medical devices. Change point analysis (CPA) detects changes in longitudinal data for a medical device without incorporating comparisons with other devices. This study investigated the temporal relationship between endoleak reports for aortic stent grafts identified using CPA and the issuance of the \u201cPharmaceuticals and Medical Devices Agency (PMDA) Alert for Proper Use of Medical Devices\u201d in Japan. Device malfunction and adverse event reports for aortic stent grafts submitted to the PMDA between April 2008 and September 2022 were analyzed. The reports were mapped to the Medical Device Problem Terminology from the Japan Federation of Medical Devices Associations. CPA was used to identify temporal changes in report counts, with change points having confidence levels\u2009\u2265\u200990% being considered significant. A total of 20,678 reports were analyzed, including 23,541 device malfunctions and 30,500 adverse events. Endoleaks accounted for 10,779 events. CPA identified a significant increase in endoleak events in April 2015 (2 years before the regulatory alert). Confidence levels exceeded 90% in 76 out of 174 evaluated time points, first in July 2008 (9 years before the alert) and next in April 2016 (1 year before the alert). Based on these findings, CPA may help prioritize investigations of medical-device-related malfunctions and adverse events. However, the results do not indicate earlier or superior signal detection relative to regulatory authorities. Further research is needed to assess CPA\u2019s applicability to other medical devices and malfunctions.<\/jats:p>","DOI":"10.1007\/s10916-026-02388-z","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T03:13:33Z","timestamp":1776914013000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Signal Detection Using Change Point Analysis to Identify Safety Signals from Spontaneous Reports in Aortic Stent Grafts in Japan"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3528-5695","authenticated-orcid":false,"given":"Kohei","family":"Takahashi","sequence":"first","affiliation":[]},{"given":"Hideto","family":"Yokoi","sequence":"additional","affiliation":[]},{"given":"Fumiaki","family":"Mikami","sequence":"additional","affiliation":[]},{"given":"Tomomi","family":"Satomi","sequence":"additional","affiliation":[]},{"given":"Morikazu","family":"Seki","sequence":"additional","affiliation":[]},{"given":"Takako Takayama","family":"Niwa","sequence":"additional","affiliation":[]},{"given":"Hideki","family":"Hanaoka","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8659-2873","authenticated-orcid":false,"given":"Yosuke","family":"Inaba","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4238-0334","authenticated-orcid":false,"given":"Daisuke","family":"Koide","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"issue":"9237","key":"2388_CR1","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","volume":"356","author":"IR Edwards","year":"2000","unstructured":"Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356(9237):1255\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(00)02799-9","journal-title":"Lancet"},{"key":"2388_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ailsci.2021.100005","volume":"1","author":"H Ibrahim","year":"2021","unstructured":"Ibrahim H, Abdo A, Kerdawy AME, Eldin AS. Signal detection in pharmacovigilance: A review of informatics-driven approaches for the discovery of drug-drug interaction signals in different data sources. Artif Intell Life Sci. 2021;1:1\u201315. https:\/\/doi.org\/10.1016\/j.ailsci.2021.100005","journal-title":"Artif Intell Life Sci"},{"key":"2388_CR3","doi-asserted-by":"publisher","first-page":"1323057","DOI":"10.3389\/fdsfr.2023.1323057","volume":"3","author":"PM Cutroneo","year":"2023","unstructured":"Cutroneo PM, Sartori D, Tuccori M, Crisafulli S, Battini V, Carnovale C, Rafaniello C, Capuano A, Poluzzi E, Moretti U, Raschi E. Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems. Front Drug Saf Regul. 2023;3:1323057. https:\/\/doi.org\/10.3389\/fdsfr.2023.1323057","journal-title":"Front Drug Saf Regul"},{"issue":"10","key":"2388_CR4","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/0895-4356(92)90158-j","volume":"45","author":"BHC Stricker","year":"1992","unstructured":"Stricker BHC, Tijssen JGP. Serum sickness-like reactions to cefaclor. J Clin Epidemiol. 1992;45(10):1177\u201384. https:\/\/doi.org\/10.1016\/0895-4356(92)90158-j","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"2388_CR5","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/pds.677","volume":"10","author":"SJ Evans","year":"2001","unstructured":"Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf. 2001;10(6):483\u20136. https:\/\/doi.org\/10.1002\/pds.677","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2388_CR6","unstructured":"Bate A. The Use of a Bayesian Confidence Propagation Neural Network in Pharmacovigilance. Ume\u00e5, Sweden: Ume\u00e5 University medical dissertations; 2003."},{"issue":"2","key":"2388_CR7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.yrtph.2011.03.015","volume":"61","author":"J Kim","year":"2011","unstructured":"Kim J, Kim M, Ha J-H, Jang J, Hwang M, Lee BK, Chung MW, Yoo TM, Kim MJ. Signal detection of methylphenidate by comparing a spontaneous reporting database with a claims database. Regul Toxicol Pharmacol. 2011;61(2):154\u201360. https:\/\/doi.org\/10.1016\/j.yrtph.2011.03.015","journal-title":"Regul Toxicol Pharmacol"},{"issue":"5","key":"2388_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1248\/bpbreports.8.5_133","volume":"8","author":"K Shingo","year":"2025","unstructured":"Shingo K, Mari M, Nozomi I, Yuko O, Hiroki I, Noriko K, Katsunori Y. Analysis of drug-induced xerostomia using the Japanese adverse drug event report database. BPB Reports. 2025;8(5):133\u20137. https:\/\/doi.org\/10.1248\/bpbreports.8.5_133","journal-title":"BPB Reports"},{"issue":"2","key":"2388_CR9","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s10115-016-0987-z","volume":"51","author":"S Aminikhanghahi","year":"2017","unstructured":"Aminikhanghahi S, Cook DJ. A survey of methods for time series change point detection. Knowl Inf Syst. 2017;51(2):339\u201367. https:\/\/doi.org\/10.1007\/s10115-016-0987-z","journal-title":"Knowl Inf Syst"},{"key":"2388_CR10","unstructured":"Basseville M, Nikiforov IV. Detection of Abrupt Changes: Theory and Application. 1993."},{"issue":"6","key":"2388_CR11","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/1467-9892.00286","volume":"23","author":"BK Ray","year":"2002","unstructured":"Ray BK, Tsay RS. Bayesian methods for change-point detection in long-range dependent processes. J Time Ser Anal. 2002;23(6):629\u2013754. https:\/\/doi.org\/10.1111\/1467-9892.00286","journal-title":"J Time Ser Anal"},{"issue":"2","key":"2388_CR12","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/jamia\/ocv063","volume":"23","author":"HJ Duggirala","year":"2016","unstructured":"Duggirala HJ, Tonning JM, Smith E, Bright RA, Baker JD, Ball R, Bell C, Bright-Ponte SJ, Botsis T, Bouri K, Boyer M, Burkhart K, Condrey GS, Chen JJ, Chirtel S, Filice RW, Francis H, Jiang H, Levine J, Martin D, Oladipo T, O\u2019Neill R, Palmer LAM, Paredes A, Rochester G, Sholtes D, Szarfman A, Wong H-L, Xu Z, Kass-Hout T. Use of data mining at the Food and Drug Administration. J Am Med Inform Assoc. 2016;23(2):428\u201334. https:\/\/doi.org\/10.1093\/jamia\/ocv063","journal-title":"J Am Med Inform Assoc"},{"issue":"4","key":"2388_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1257\/jep.15.4.117","volume":"15","author":"BE Hansen","year":"2001","unstructured":"Hansen BE. The new econometrics of structural change: dating breaks in U.S. labor productivity. J Econ Perspect. 2001;15(4):117\u201328. https:\/\/doi.org\/10.1257\/jep.15.4.117","journal-title":"J Econ Perspect"},{"issue":"3","key":"2388_CR14","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.neuroimage.2007.01.004","volume":"35","author":"MA Lindquist","year":"2007","unstructured":"Lindquist MA, Waugh C, Wager TD. Modeling state-related fMRI activity using change-point theory. Neuroimage. 2007;35(3):1125\u201341. https:\/\/doi.org\/10.1016\/j.neuroimage.2007.01.004","journal-title":"Neuroimage"},{"key":"2388_CR15","doi-asserted-by":"publisher","unstructured":"You S-H, Jang EJ, Kim M-S, Lee M-T, Kang Y-J, Lee J-E, Eom J-H, Jung S-Y. Change point analysis for detecting vaccine safety signals. Vaccines (Basel). 2021;9(3). https:\/\/doi.org\/10.3390\/vaccines9030206","DOI":"10.3390\/vaccines9030206"},{"issue":"6","key":"2388_CR16","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/pds.3783","volume":"24","author":"Z Xu","year":"2015","unstructured":"Xu Z, Kass-Hout T, Anderson-Smits C, Gray G. Signal detection using change point analysis in postmarket surveillance. Pharmacoepidemiol Drug Saf. 2015;24(6):663\u20138. https:\/\/doi.org\/10.1002\/pds.3783","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"2388_CR17","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/pds.4613","volume":"28","author":"NTH Trinh","year":"2019","unstructured":"Trinh NTH, Sol\u00e9 E, Benkebil M. Benefits of combining change-point analysis with disproportionality analysis in pharmacovigilance signal detection. Pharmacoepidemiol Drug Saf. 2019;28(3):370\u20136. https:\/\/doi.org\/10.1002\/pds.4613","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"2388_CR18","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.3233\/THC-220284","volume":"30","author":"A Badnjevi\u0107","year":"2022","unstructured":"Badnjevi\u0107 A, Pokvi\u0107 LG, Deumi\u0107 A, Be\u0107irovi\u0107 LS. Post-market surveillance of medical devices: A review. Technol Health Care. 2022;30(6):1315\u201329. https:\/\/doi.org\/10.3233\/THC-220284","journal-title":"Technol Health Care"},{"issue":"9","key":"2388_CR19","doi-asserted-by":"publisher","first-page":"e1001519","DOI":"10.1371\/journal.pmed.1001519","volume":"10","author":"DB Kramer","year":"2013","unstructured":"Kramer DB, Tan YT, Sato C, Kesselheim AS. Postmarket surveillance of medical devices: a comparison of strategies in the US, EU, Japan, and China. PLoS Med. 2013;10(9):e1001519. https:\/\/doi.org\/10.1371\/journal.pmed.1001519","journal-title":"PLoS Med"},{"key":"2388_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/MDER.S278868","volume":"14","author":"J Pane","year":"2021","unstructured":"Pane J, Verhamme KM, Villegas D, Gamez L, Rebollo I, Sturkenboom MC. Challenges associated with the safety signal detection process for medical devices. Med Devices (Auckl). 2021;14:43\u201357. https:\/\/doi.org\/10.2147\/MDER.S278868","journal-title":"Med Devices (Auckl)"},{"issue":"1","key":"2388_CR21","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1186\/s12913-024-11885-1","volume":"24","author":"SJ Choi","year":"2024","unstructured":"Choi SJ, Choi S, Park S, Nam KC, Jang HJ, Kim JK, Lee YK, Ishikawa H, Woo E. The application study of harmonization code in medical device adverse event reporting. BMC Health Serv Res. 2024;24(1):1402. https:\/\/doi.org\/10.1186\/s12913-024-11885-1","journal-title":"BMC Health Serv Res"},{"issue":"23","key":"2388_CR22","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1093\/bioinformatics\/bts576","volume":"28","author":"K Johnson","year":"2012","unstructured":"Johnson K, Guo C, Gosink M, Wang V, Hauben M. Multinomial modeling and an evaluation of common data-mining algorithms for identifying signals of disproportionate reporting in pharmacovigilance databases. Bioinformatics. 2012;28(23):3123\u201330. https:\/\/doi.org\/10.1093\/bioinformatics\/bts576","journal-title":"Bioinformatics"},{"issue":"4","key":"2388_CR23","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/pds.4980","volume":"29","author":"G Chung","year":"2020","unstructured":"Chung G, Etter K, Yoo A. Medical device active surveillance of spontaneous reports: A literature review of signal detection methods. Pharmacoepidemiol Drug Saf. 2020;29(4):369\u201379. https:\/\/doi.org\/10.1002\/pds.4980","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"2388_CR24","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s43441-022-00415-y","volume":"56","author":"HY Garashi","year":"2022","unstructured":"Garashi HY, Steinke DT, Schafheutle EI. A Systematic Review of Pharmacovigilance Systems in Developing Countries Using the WHO Pharmacovigilance Indicators. Ther Innov Regul Sci. 2022;56(5):717\u201343. https:\/\/doi.org\/10.1007\/s43441-022-00415-y","journal-title":"Ther Innov Regul Sci"},{"key":"2388_CR25","unstructured":"Pharmaceuticals and Medical Devices Agency. Reporting System under the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices by manufactures [cited 2025 12\/01] [Available from: https:\/\/www.pmda.go.jp\/safety\/reports\/mah\/0008.html."},{"key":"2388_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2147\/MDER.S12396","volume":"3","author":"P Gupta","year":"2010","unstructured":"Gupta P, Janodia MD, Jagadish PC, Udupa N. Medical device vigilance systems: India, US, UK, and Australia. Med Devices (Auckl). 2010;3:67\u201379. https:\/\/doi.org\/10.2147\/MDER.S12396","journal-title":"Med Devices (Auckl)"},{"issue":"5","key":"2388_CR27","doi-asserted-by":"publisher","first-page":"e39775","DOI":"10.7759\/cureus.39775","volume":"15","author":"VR Yanamaladoddi","year":"2023","unstructured":"Yanamaladoddi VR, Sarvepalli SS, Vemula SL, Aramadaka S, Mannam R, Narayanan RS, Bansal A. The challenge of endoleaks in endovascular aneurysm repair (EVAR): A review of their types and management. Cureus. 2023;15(5):e39775. https:\/\/doi.org\/10.7759\/cureus.39775","journal-title":"Cureus"},{"key":"2388_CR28","unstructured":"Pharmaceuticals and Medical Devices Agency. PMDA Alert for Proper Use of Medical Devices 2017 [cited 2025 12\/01] [Available from: https:\/\/www.pmda.go.jp\/files\/000219008.pdf."},{"issue":"2","key":"2388_CR29","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jacbts.2022.12.011","volume":"8","author":"GAV Norman","year":"2023","unstructured":"Norman GAV. Off-Label use vs Off-Label marketing of drugs: Part 1: Off-Label use-patient harms and prescriber responsibilities. JACC Basic Transl Sci. 2023;8(2):224\u201333. https:\/\/doi.org\/10.1016\/j.jacbts.2022.12.011","journal-title":"JACC Basic Transl Sci"},{"issue":"6","key":"2388_CR30","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.jacc.2007.10.028","volume":"51","author":"CL Grines","year":"2008","unstructured":"Grines CL. Off-Label use of drug-eluting stents putting it in perspective. J Am Coll Cardiol. 2008;51(6):615\u20137. https:\/\/doi.org\/10.1016\/j.jacc.2007.10.028","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"2388_CR31","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1002\/pds.4252","volume":"26","author":"C Ishiguro","year":"2017","unstructured":"Ishiguro C, Misu T, Iwasa E, Izawa T. Analysis of safety-related regulatory actions by Japan\u2019s pharmaceutical regulatory agency. Pharmacoepidemiol Drug Saf. 2017;26(11):1314\u201320. https:\/\/doi.org\/10.1002\/pds.4252","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"2388_CR32","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00270-023-03629-1","volume":"47","author":"J-Y Chun","year":"2024","unstructured":"Chun J-Y, Haan Md, Maleux G, Osman A, Cannavale A, Morgan R. CIRSE standards of practice on management of endoleaks following endovascular aneurysm repair. Cardiovasc Intervent Radiol. 2024;47(2):161\u201376. https:\/\/doi.org\/10.1007\/s00270-023-03629-1","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2388_CR33","unstructured":"The Japan Federation of Medical Devices Associations. Utilization of the Medical Device Malfunction Terminology Database [cited 2025 12\/01] [Available from: https:\/\/www.jfmda.gr.jp\/activity\/committee\/fuguai\/."},{"key":"2388_CR34","doi-asserted-by":"publisher","unstructured":"Becker BFH, Avillach P, Romio S, Mulligen EMv, Weibel D, Sturkenboom MCJM, Kors JA, consortium A. CodeMapper: semiautomatic coding of case definitions. A contribution from the ADVANCE project. Pharmacoepidemiol Drug Saf. 2017;26(8):998\u20131005. https:\/\/doi.org\/10.1002\/pds.4245","DOI":"10.1002\/pds.4245"},{"key":"2388_CR35","unstructured":"Taylor WA. Change-Point Analysis: A Powerful New Tool For Detecting Changes: Taylor Enterprises, Inc; [Available from: https:\/\/variation.com\/wp-content\/uploads\/change-point-analyzer\/change-point-analysis-a-powerful-new-tool-for-detecting-changes.pdf."},{"key":"2388_CR36","doi-asserted-by":"crossref","unstructured":"Efron B, Tibshirani RJ. An Introduction to the Bootstrap. 1st Edition ed. New York: Chapman and Hall\/CRC; 1994.","DOI":"10.1201\/9780429246593"},{"issue":"4","key":"2388_CR37","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/pts.0b013e3181fd1697","volume":"6","author":"DJ Noble","year":"2010","unstructured":"Noble DJ, Pronovost PJ. Underreporting of patient safety incidents reduces health care\u2019s ability to quantify and accurately measure harm reduction. J Patient Saf. 2010;6(4):247\u201350. https:\/\/doi.org\/10.1097\/pts.0b013e3181fd1697","journal-title":"J Patient Saf"},{"issue":"5","key":"2388_CR38","doi-asserted-by":"publisher","first-page":"e0126413","DOI":"10.1371\/journal.pone.0126413","volume":"10","author":"S Matsuda","year":"2015","unstructured":"Matsuda S, Aoki K, Kawamata T, Kimotsuki T, Kobayashi T, Kuriki H, Nakayama T, Okugawa S, Sugimura Y, Tomita M, Takahashi Y. Bias in spontaneous reporting of adverse drug reactions in Japan. PLoS One. 2015;10(5):e0126413. https:\/\/doi.org\/10.1371\/journal.pone.0126413","journal-title":"PLoS One"},{"issue":"12","key":"2388_CR39","doi-asserted-by":"publisher","first-page":"e0144263","DOI":"10.1371\/journal.pone.0144263","volume":"10","author":"M Hashiguchi","year":"2015","unstructured":"Hashiguchi M, Imai S, Uehara K, Maruyama J, Shimizu M, Mochizuki M. Factors affecting the timing of signal detection of adverse drug reactions. PLoS One. 2015;10(12):e0144263. https:\/\/doi.org\/10.1371\/journal.pone.0144263","journal-title":"PLoS One"},{"key":"2388_CR40","doi-asserted-by":"publisher","unstructured":"Steadman JA, Mendes BC, b GSO. Technique of partial open surgical stent graft explantation with preservation of fenestrated stent graft component to treat recalcitrant type II endoleak. J Vasc Surg Cases Innov Tech. 2022;8(3):500-4. https:\/\/doi.org\/10.1016\/j.jvscit.2022.05.020","DOI":"10.1016\/j.jvscit.2022.05.020"},{"issue":"3","key":"2388_CR41","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/europace\/eup375","volume":"12","author":"RG Hauser","year":"2010","unstructured":"Hauser RG, Katsiyiannis WT, Gornick CC, Almquist AK, Kallinen LM. Deaths and cardiovascular injuries due to device-assisted implantable cardioverter-defibrillator and pacemaker lead extraction. Europace. 2010;12(3):395\u2013401. https:\/\/doi.org\/10.1093\/europace\/eup375","journal-title":"Europace"},{"issue":"1","key":"2388_CR42","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12911-022-01748-2","volume":"22","author":"A Yagahara","year":"2022","unstructured":"Yagahara A, Yokoi H. Terminology integration and inconsistency identification of adverse event terminology for Japanese medical devices using SPARQL. BMC Med Inform Decis Mak. 2022;22(1):16. https:\/\/doi.org\/10.1186\/s12911-022-01748-2","journal-title":"BMC Med Inform Decis Mak"}],"container-title":["Journal of Medical Systems"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10916-026-02388-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10916-026-02388-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10916-026-02388-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T03:13:39Z","timestamp":1776914019000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10916-026-02388-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2388"],"URL":"https:\/\/doi.org\/10.1007\/s10916-026-02388-z","relation":{},"ISSN":["1573-689X"],"issn-type":[{"value":"1573-689X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]},"assertion":[{"value":"16 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research approved by the Kagawa University Faculty of Medicine Ethics Committee (Approval Number: 2023\u2009\u2212\u2009133).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}